Comparison of mild and moderate to severe degree pancreatitis after endoscopic retrograde cholangiopancreatography

IF 0.3 Q4 GASTROENTEROLOGY & HEPATOLOGY
Wei-Chih Sun, Wen-Chi Chen, Wei-Lun Tsai, Feng-Woei Tsay, Huay-Min Wang, Yun-Da Li, Tzung-Jiun Tsai
{"title":"Comparison of mild and moderate to severe degree pancreatitis after endoscopic retrograde cholangiopancreatography","authors":"Wei-Chih Sun,&nbsp;Wen-Chi Chen,&nbsp;Wei-Lun Tsai,&nbsp;Feng-Woei Tsay,&nbsp;Huay-Min Wang,&nbsp;Yun-Da Li,&nbsp;Tzung-Jiun Tsai","doi":"10.1002/aid2.13427","DOIUrl":null,"url":null,"abstract":"<p>Pancreatitis is the most common and devastating adverse event of endoscopic retrograde cholangiopancreatography (ERCP). Post-ERCP pancreatitis (PEP) is mostly mild, but some can progress to more severe conditions with lethal outcomes. Although many risk factors and preventive measures for the occurrence of PEP have been established, there are insufficient studies to compare mild and moderate to severe PEP for the determination of predictors in the severity. This study looked at the eligibility of 4407 patients who had ERCP in a tertiary care hospital between January 2010 and December 2021. Of the 2512 eligible patients, 155 (6.2%) had a diagnosis of PEP, with 113 (4.5%) having a mild degree, 29 (1.2%) having a moderate degree, and 13 (0.5%) having a severe degree. Baseline profiles, intraprocedural data, and post-ERCP outcomes were compared between mild PEP (A) and moderate to severe PEP (B). Group B had a longer median time to resume oral intake or enteral feeding after ERCP (5 vs. 2 days; <i>p</i> = .01) and hospital day (18 vs. 6 days; <i>p</i> = .01) than group A. There was 1 PEP-related death in group B, but the mortality rate was not different between the two groups. The proportion of patients with a common bile duct diameter ≤10 mm (54.0% vs. 35.7%; <i>p</i> = .04), overall biliary cannulation time &gt;10 min (61.9% vs. 38.1%; <i>p</i> = .01), and concurrent post-ERCP complications (16.7% vs. 3.5%; <i>p</i> = .01) was higher in group B than in group A. The main difference in concurrent post-ERCP complications was micro-perforation, which occurred in 11.9% of group B and 0.9% of group A (<i>p</i> = .01). Overall biliary cannulation time &gt;10 min (odds ratio [OR]: 2.90; 95% confidence interval [CI] = 1.19–7.07; <i>p</i> = .02) and concurrent post-ERCP complications (OR: 5.60; 95% CI = 1.17–26.76; <i>p</i> = .03) were found to be independent predictors of moderate to severe PEP. Selective biliary cannulation time &gt;10 min and concurrent post-ERCP complications are risk factors for moderate to severe PEP.</p>","PeriodicalId":7278,"journal":{"name":"Advances in Digestive Medicine","volume":"12 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/aid2.13427","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Digestive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/aid2.13427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pancreatitis is the most common and devastating adverse event of endoscopic retrograde cholangiopancreatography (ERCP). Post-ERCP pancreatitis (PEP) is mostly mild, but some can progress to more severe conditions with lethal outcomes. Although many risk factors and preventive measures for the occurrence of PEP have been established, there are insufficient studies to compare mild and moderate to severe PEP for the determination of predictors in the severity. This study looked at the eligibility of 4407 patients who had ERCP in a tertiary care hospital between January 2010 and December 2021. Of the 2512 eligible patients, 155 (6.2%) had a diagnosis of PEP, with 113 (4.5%) having a mild degree, 29 (1.2%) having a moderate degree, and 13 (0.5%) having a severe degree. Baseline profiles, intraprocedural data, and post-ERCP outcomes were compared between mild PEP (A) and moderate to severe PEP (B). Group B had a longer median time to resume oral intake or enteral feeding after ERCP (5 vs. 2 days; p = .01) and hospital day (18 vs. 6 days; p = .01) than group A. There was 1 PEP-related death in group B, but the mortality rate was not different between the two groups. The proportion of patients with a common bile duct diameter ≤10 mm (54.0% vs. 35.7%; p = .04), overall biliary cannulation time >10 min (61.9% vs. 38.1%; p = .01), and concurrent post-ERCP complications (16.7% vs. 3.5%; p = .01) was higher in group B than in group A. The main difference in concurrent post-ERCP complications was micro-perforation, which occurred in 11.9% of group B and 0.9% of group A (p = .01). Overall biliary cannulation time >10 min (odds ratio [OR]: 2.90; 95% confidence interval [CI] = 1.19–7.07; p = .02) and concurrent post-ERCP complications (OR: 5.60; 95% CI = 1.17–26.76; p = .03) were found to be independent predictors of moderate to severe PEP. Selective biliary cannulation time >10 min and concurrent post-ERCP complications are risk factors for moderate to severe PEP.

Abstract Image

内镜逆行胰胆管造影后轻度与中度至重度胰腺炎的比较
胰腺炎是内镜逆行胰胆管造影(ERCP)最常见和最具破坏性的不良事件。ercp后胰腺炎(PEP)大多是轻微的,但有些可能发展到更严重的情况,导致致命的结果。虽然已经确定了许多PEP发生的危险因素和预防措施,但没有足够的研究来比较轻度和中度至重度PEP,以确定其严重程度的预测因素。这项研究调查了2010年1月至2021年12月在一家三级医院接受ERCP治疗的4407名患者的资格。在2512例符合条件的患者中,155例(6.2%)诊断为PEP,其中113例(4.5%)为轻度,29例(1.2%)为中度,13例(0.5%)为重度。比较了轻度PEP (A)和中重度PEP (B)的基线概况、术中数据和ERCP后结果。B组在ERCP后恢复口服或肠内喂养的中位时间更长(5天vs. 2天;P = 0.01)和住院天数(18天vs. 6天;p = 0.01),与a组相比,B组有1例pep相关死亡,但两组间死亡率无显著差异。总胆管直径≤10 mm的患者比例(54.0% vs. 35.7%;P = 0.04),总胆道插管时间10min (61.9% vs. 38.1%;p = 0.01),并发ercp后并发症(16.7% vs. 3.5%;p = 0.01)高于A组。ercp术后并发并发症的主要差异是微穿孔,B组为11.9%,A组为0.9% (p = 0.01)。总胆道插管时间10min(优势比[OR]: 2.90;95%置信区间[CI] = 1.19-7.07;p = .02)和并发ercp后并发症(OR: 5.60;95% ci = 1.17-26.76;p = .03)是中度至重度PEP的独立预测因子。选择性胆道插管时间10min及并发ercp后并发症是中重度PEP的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Digestive Medicine
Advances in Digestive Medicine GASTROENTEROLOGY & HEPATOLOGY-
自引率
33.30%
发文量
42
期刊介绍: Advances in Digestive Medicine is the official peer-reviewed journal of GEST, DEST and TASL. Missions of AIDM are to enhance the quality of patient care, to promote researches in gastroenterology, endoscopy and hepatology related fields, and to develop platforms for digestive science. Specific areas of interest are included, but not limited to: • Acid-related disease • Small intestinal disease • Digestive cancer • Diagnostic & therapeutic endoscopy • Enteral nutrition • Innovation in endoscopic technology • Functional GI • Hepatitis • GI images • Liver cirrhosis • Gut hormone • NASH • Helicobacter pylori • Cancer screening • IBD • Laparoscopic surgery • Infectious disease of digestive tract • Genetics and metabolic disorder • Microbiota • Regenerative medicine • Pancreaticobiliary disease • Guideline & consensus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信